Company intelligence / Profile preview
Oystershell
- Ownership
- Private
- Employees
- ~65
- Development stage
- Other
Overview
Oystershell develops and markets innovative over-the-counter healthcare products with leading positions in lice treatment (#1 globally after acquiring RID), wart cryotherapy treatments, and other self-care categories. Products are sold under its own brands and through partners in over 80 countries. The company emphasizes scientific validation and consumer convenience. Recent clinical results or trial data are not publicly detailed due to the OTC nature of most products.
- Therapeutic areas
- Metabolic DisordersDermatologyInfectious Diseases
- Modalities
- Small molecules (OTC drugs)Medical devicesBiocidesCosmeticsFood supplements
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Oystershell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oystershell.